These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29739103)

  • 1. Bacteramia Caused by Gardnerella Vaginalis in a Cesarean Section Patient.
    Chen Y; Han X; Guo P; Huang H; Wu Z; Liao K
    Clin Lab; 2018 Mar; 64(3):379-382. PubMed ID: 29739103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gardnerella Vaginalis Bacteremia in a Pregnant Woman with Vaginal Myomectomy.
    Tian PP; Fan W; Zhu LS; Yi HW
    Clin Lab; 2024 Mar; 70(3):. PubMed ID: 38469790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Septic shock caused by Gardnerella vaginalis and Peptostreptococcus species after Cesarean section].
    Datcu R; Charib K; Kjaeldgaard P
    Ugeskr Laeger; 2009 Mar; 171(12):1012. PubMed ID: 19284925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy.
    Bradshaw CS; Tabrizi SN; Fairley CK; Morton AN; Rudland E; Garland SM
    J Infect Dis; 2006 Sep; 194(6):828-36. PubMed ID: 16941351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Biofilm Formation by Gardnerella vaginalis and Other Anaerobes on Bacterial Vaginosis.
    Machado A; Cerca N
    J Infect Dis; 2015 Dec; 212(12):1856-61. PubMed ID: 26080369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of Compounds against Gardnerella vaginalis Biofilms.
    Gottschick C; Szafranski SP; Kunze B; Sztajer H; Masur C; Abels C; Wagner-Döbler I
    PLoS One; 2016; 11(4):e0154086. PubMed ID: 27111438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model.
    Schwebke JR; Muzny CA; Josey WE
    J Infect Dis; 2014 Aug; 210(3):338-43. PubMed ID: 24511102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gardnerella vaginalis bacteremia associated with severe acute encephalopathy in a young female patient.
    Tankovic J; Timinskas A; Janulaitiene M; Zilnyte M; Baudel JL; Maury E; Zvirbliene A; Pleckaityte M
    Anaerobe; 2017 Oct; 47():132-134. PubMed ID: 28546029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BV and non-BV associated Gardnerella vaginalis establish similar synergistic interactions with other BV-associated microorganisms in dual-species biofilms.
    Castro J; Cerca N
    Anaerobe; 2015 Dec; 36():56-9. PubMed ID: 26505928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo.
    Hymes SR; Randis TM; Sun TY; Ratner AJ
    J Infect Dis; 2013 May; 207(10):1491-7. PubMed ID: 23431033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gardnerella vaginalis bacteremia in a premature neonate.
    Amaya RA; Al-Dossary F; Demmler GJ
    J Perinatol; 2002; 22(7):585-7. PubMed ID: 12368979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycoplasma hominis and Gardnerella vaginalis display a significant synergistic relationship in bacterial vaginosis.
    Cox C; Watt AP; McKenna JP; Coyle PV
    Eur J Clin Microbiol Infect Dis; 2016 Mar; 35(3):481-7. PubMed ID: 26796553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis.
    Gilbert NM; Lewis WG; Lewis AL
    PLoS One; 2013; 8(3):e59539. PubMed ID: 23527214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility and vaginolysin in Gardnerella vaginalis from healthy and bacterial vaginosis diagnosed women.
    Knupp de Souza DM; Diniz CG; Filho DS; Andrade de Oliveira LM; Coelho DM; Talha LS; Nascimento TC; Ferreira-Machado AB; Silva VL
    J Infect Dev Ctries; 2016 Sep; 10(9):913-919. PubMed ID: 27694723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gardnerella vaginalis in infections of reproductive organs].
    Kasprowicz A; Białecka A
    Med Dosw Mikrobiol; 1993; 45(2):199-203. PubMed ID: 8309297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gardnerella vaginalis: An overlooked pathogen in male patients?
    Babics A; Roussellier P
    Med Mal Infect; 2015 Oct; 45(10):423-4. PubMed ID: 26472061
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of intrinsically metronidazole-resistant clades of Gardnerella vaginalis.
    Schuyler JA; Mordechai E; Adelson ME; Sobel JD; Gygax SE; Hilbert DW
    Diagn Microbiol Infect Dis; 2016 Jan; 84(1):1-3. PubMed ID: 26514076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial vaginosis: what is physiological in vaginal bacteriology? An update and opinion.
    Leppäluoto PA
    Acta Obstet Gynecol Scand; 2011 Dec; 90(12):1302-6. PubMed ID: 21916857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates.
    Castro J; Alves P; Sousa C; Cereija T; França Â; Jefferson KK; Cerca N
    Sci Rep; 2015 Jun; 5():11640. PubMed ID: 26113465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysozyme as a cotreatment during antibiotics use against vaginal infections: An in vitro study on Gardnerella vaginalis biofilm models.
    Thellin O; Zorzi W; Zorzi D; Delvenne P; Heinen E; ElMoualij B; Quatresooz P
    Int Microbiol; 2016 Jun; 19(2):101-107. PubMed ID: 27845497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.